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Abstract
 
We investigated the role of Fas ligand in murine silicosis. Wild-type mice instilled with silica
developed severe pulmonary inflammation, with local production of tumor necrosis factor
(TNF)-
 
 
 
, and interstitial neutrophil and macrophage infiltration in the lungs. Strikingly, Fas
ligand–deficient generalized lymphoproliferative disease mutant (
 
gld
 
) mice did not develop sili-
cosis. The 
 
gld
 
 mice had markedly reduced neutrophil extravasation into bronchoalveolar space,
and did not show increased TNF-
 
 
 
 production, nor pulmonary inflammation. Bone marrow
chimeras and local adoptive transfer demonstrated that wild-type, but not Fas ligand–deficient
lung macrophages recruit neutrophils and initiate silicosis. Silica induced Fas ligand expression
in lung macrophages in vitro and in vivo, and promoted Fas ligand–dependent macrophage ap-
optosis. Administration of neutralizing anti-Fas ligand antibody in vivo blocked induction of
silicosis. Thus, Fas ligand plays a central role in induction of pulmonary silicosis.
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Introduction
 
The deposition of silica particles in the lungs of man and ex-
perimental animals leads to silicosis, an industrial era disease
that causes respiratory failure due to a fibrotic reaction (1–3).
Occupations such as coal mining and quarrying increase
the risk of developing silicosis (1, 2). Silicosis starts with in-
flammation and tissue destruction, followed by tissue repair
that leads to fibrosis (1–3). After reaching the alveoli, silica
particles are ingested by pulmonary macrophages, which
become activated and release inflammatory mediators, such
as reactive oxygen intermediates, arachdonic acid metabo-
lites, chemokines, and cytokines (1–3). Activated macro-
phages attract neutrophilic granulocytes, which upregulate
alveolitis and promote connective tissue destruction (3).
The proinflammatory cytokine TNF-
 
 
 
 plays a pivotal role
in silicosis by mediating the widespread inflammatory reac-
tion and inducing the late fibrogenic reaction (3, 4).
Fas ligand (FasL) is a membrane bound and shed protein
belonging to the TNF gene family, and the natural counter-
receptor for the death-promoting Fas molecule expressed by
a variety of lymphoid and nonlymphoid tissues (5). Lympho-
cyte apoptosis mediated by Fas/FasL interaction regulates
immune responses (6, 7), and FasL-mediated apoptosis of
leukocytes prevents inflammatory reactions at immune-priv-
ileged sites (8). However, FasL also exerts a proinflammatory
role. Tumors expressing FasL are destroyed by infiltrating
granulocytes in vivo (9, 10). Microenvironmental influence,
such as TGF-
 
 
 
, appears to determine suppressive versus in-
flammatory effects of FasL (11). Here we show that silica-
induced pulmonary inflammation requires FasL expression
and that FasL-expressing pulmonary macrophages attract
neutrophils and initiate silicosis. Blockade of FasL function
by antibodies prevents development of silicosis in vivo.
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Materials and Methods
 
Animals.
 
Wild-type (wt)
 
*
 
 BALB/c (BALB.wt) and BALB
generalized lymphoproliferative disease mutant
 
 
 
(
 
gld
 
)
 
/gld
 
 (BALB.
 
gld
 
) mice of both sexes (aging 6–8 wk, weighing 25–30 g) were
from the Oswaldo Cruz Institute Animal Care facility, Rio de Ja-
neiro. BALB.
 
gld
 
 mice were produced at the National Cancer In-
stitute, National Institutes of Health, Bethesda, MD, by serially
backcrossing the 
 
gld
 
 gene onto a BALB/c background for 15
generations. All animal work in this study was conducted in ac-
cordance with humane institutional guidelines.
 
Silica Instillation.
 
Mice were anesthetized by sevoflurane and
tracheotomyzed. Mice received an intratracheal injection of 50
 
 
 
l of either sterile saline or silica suspension (SiO
 
2
 
; 20 mg/50 
 
 
 
l
in sterile saline, 1–5-
 
 
 
m sterile particles; Sigma-Aldrich).
 
Respiratory Mechanics.
 
After 15 d of silica instillation, mice
were sedated (diazepam, 1.0 mg intraperitoneally), anesthetized
(sodium pentobarbital, 2.0 mg/kg intraperitoneally), and a 20 G
gauge cannula was introduced into the trachea. Air flow (12),
volume, and total (
 
 
 
P
 
tot
 
), resistive (
 
 
 
P
 
1
 
), and viscoelastic/inho-
mogeneous (
 
 
 
P
 
2
 
) pressures (13) were measured. All data were
analyzed using ANADAT software (RHT-Info Data Inc.). Data
are presented as means 
 
 
 
 SEM of 8–10 mice per group.
 
Histopathology, Immunohistochemistry, Immunofluorescence, and In
Situ Detection of Apoptosis.
 
Animals were killed by cervical dislo-
cation. The pulmonary circulation was flushed by intracardiac in-
jection of saline, followed by formaline. Lungs were fixed in 10%
formaline, embedded in paraffin, and sections were stained with
hematoxylin and eosin for histopathological analysis. Alter-
natively, lung cryostat sections (4–10 
 
 
 
m) were embedded in
OCT Tissue-Tek (Sakura Finetek Inc.), and mounted on poly-
 
l
 
-lysine–coated glass microscope slides. FasL and Fas were detected
with anti–mouse FasL mAb MFL3, and anti–mouse Fas mAb Jo2
(both from BD PharMingen), incubated at 5 
 
 
 
g/ml, and devel-
oped with horseradish peroxidase (HRP)-conjugated goat anti–
hamster Ig (Sigma-Aldrich). Negative controls were stained with
5 
 
 
 
g/ml control hamster IgG (anti-TNP mAb A19-3; BD
PharMingen). For double staining immunofluorescence, cryostat
sections were treated with 5 
 
 
 
g/ml Fc block (anti-Fc
 
 
 
 RII/III
mAb 2.4G2; BD PharMingen), and stained with 5 
 
 
 
g/ml PE- or
FITC-labeled control hamster IgG, PE-labeled anti–mouse FasL
MFL3, and FITC-labeled anti–mouse F4/80 (a macrophage sur-
face marker; Caltag Laboratories) mAbs. Slides were examined
with an Axiophot-2 ZEISS fluorescence microscope equipped
with differential interference contrast microscopy (DIC; reference
14). DNA fragmentation associated with apoptosis was detected
by terminal deoxynucleotidyltransferase (TdT)-mediated dUTP
nick-end labeling (TUNEL), using TdT-FragEL™ detection kit
(Oncogene Research Products), according to the manufacturer’s
instructions. Slides were developed with streptavidin-HRP con-
jugate, counterstained with methyl green, and mounted for pho-
tomicroscopy. In addition, lungs were subjected to intrabronchial
lavage (three washes of 500 
 
 
 
l saline each). Cells from bronchoal-
veolar lavage (BAL) fluid were cytocentrifuged, and stained with
May-Grunwald stain (Sigma-Aldrich).
 
Myeloperoxidase Activity.
 
Neutrophil content in BAL fluid or
pulmonary parenchyma was evaluated by measuring myeloperox-
idase (MPO) activity, as described (15). After collecting BAL
fluid, individual lungs were homogenized in 1.0 ml PBS-Tri-
ton X-100, 0.1%. Homogenized samples were centrifuged at
10,000 
 
g
 
, for 15 min at 4
 
 
 
C, and the supernatants (50 
 
 
 
l) were
added to 50 
 
 
 
l substrate solution containing 5 mM 
 
o
 
-phenylene
diamine (Sigma-Aldrich) in 10 mM citrate buffer pH 5.0, and 8.8
mM H
 
2
 
O
 
2
 
. The reaction was stopped after 15 min with 50 
 
 
 
l
H
 
2
 
SO
 
4
 
 4 N, and the absorbance was read at 492 nm. BAL cells
from either individual (silica treated) or pooled (saline treated)
mice were centrifuged, counted, and adjusted to a concentration
of 10
 
7
 
 cells/ml in PBS. Cells (50 
 
 
 
l) were added to 50 
 
 
 
l sub-
strate solution, and the reaction was processed and read as above.
Results shown are from individual mice, and each point repre-
sents the mean of triplicate readings, except for BAL from control
mice (each point is the mean of pools from three mice).
 
Bone Marrow Radiation Chimeras.
 
Chimeras were generated as
described (16). Male BALB.wt and BALB.
 
gld 
 
mice, aging 8 wk,
received acidified drinking water and ciprofloxacin (daily injection
of 100 
 
 
 
g/mouse, intraperitoneally) for 15 d before irradiation.
Immediately after irradiation (750 rad), mice received 5 
 
 
 
 10
 
6
 
bone marrow cells (in 0.1 ml DMEM) from male BALB.
 
gld
 
 and
BALB.wt donors, by intravenous route. After cell transfer, animals
were maintained in sterile isolators, and received oral gentami-
cin (0.3 mg/ml in drinking water) throughout the experiment.
The following chimeras were generated: BALB.wt
 
→
 
BALB.wt,
BALB.
 
gld
 
→
 
BALB.
 
gld
 
, BALB.wt
 
→
 
BALB.
 
gld
 
, and BALB.
 
gld
 
→
 
BALB.wt. After 30 d of bone marrow transfer, chimeras were in-
stilled intratracheally with saline or silica. Development of silicosis
was evaluated after 15 d, by lung MPO activity and histopatholog-
ical analysis.
 
Local Adoptive Transfer of Macrophages.
 
Alveolar macrophages
were obtained from BAL fluids of normal BALB.wt and
BALB.
 
gld
 
 donors (containing 
 
 
 
95% macrophages). Male BALB.
wt or BALB.
 
gld
 
 mice were instilled intratracheally with donor
macrophages (10
 
6
 
 cells/animal in 50 
 
 
 
l PBS). After 5 d of macro-
phage transfer, animals were instilled again with either saline or
silica. Development of silicosis was evaluated after 15 d of silica
instillation, by interstitial lung MPO activity and histopathologi-
cal analysis. Some BALB.wt and BALB.
 
gld
 
 mice received only sa-
line or silica instillation, and were used as negative and positive
controls for lung MPO activity.
 
FasL Expression by Lung Macrophages In Vitro.
 
As internalized
silica interferes with flow cytometry, we employed a cell ELISA
assay for FasL expression. BAL cells from normal BALB.wt mice
(2 
 
 
 
 10
 
5
 
/ml in Hank’s solution) were seeded (0.2 ml/well) on
sterile flat bottom 96-well plates (Corning), and incubated for
2 h at 37
 
 
 
C and 5% CO
 
2
 
. Residual nonadherent cells were re-
moved, and adherent lung macrophages were cultured overnight
in DMEM supplemented with 5% heat-inactivated FCS, 2 mM
 
l
 
-glutamine, 5 
 
 
 
 10
 
 
 
5
 
 M 2-ME, 10 
 
 
 
g/ml gentamicin sulfate,
MEM nonessential aminoacids, 1 mM sodium pyruvate, and 10
mM HEPES. Macrophages were then treated with either me-
dium alone, or 50 
 
 
 
g/ml silica particles (Sigma-Aldrich), in the
presence or absence of 1 mM deferoxamine (Sigma-Aldrich),
and cultured for additional 48 h. Plates were washed, fixed with
1% paraformaldehyde for 30 min, blocked with PBS-10% FCS
for 60 min, washed with PBS-Tween 20 (0.05%), and incubated
overnight with 5 
 
 
 
g/ml anti–mouse FasL mAb MFL3 (BD
PharMingen) in PBS-FCS, at 4
 
 
 
C. Wells were washed, and the
reaction was developed with secondary HRP-conjugated goat
anti–hamster Ig (Sigma-Aldrich), and 
 
o
 
-phenylene diamine as
substrate. Results are mean and SE of absorbance readings of
triplicate cultures.
 
Macrophage Apoptosis.
 
BAL cells from normal BALB.wt and
BALB.
 
gld
 
 mice (4 
 
 
 
 10
 
5
 
) were seeded and cultured on 24-well
 
*
 
Abbreviations used in this paper:
 
 BAL, bronchoalveolar lavage; HRP,
horseradish peroxidase; MPO, myeloperoxidase; wt, wild-type. 
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Corning plates (0.25 ml/well) in triplicates, as above. Macro-
phages were treated or not with 100 
 
 
 
g/ml silica particles, in the
presence of anti-FasL mAb MFL3 or a control hamster IgG (20
 
 
 
g/ml), and cultured for 24 h. As apoptotic macrophages detach
from the plates, the resulting non-adherent cells were harvested,
counted, cytocentrifuged, and stained with May-Grunwald. Ap-
optotic cells were identified on oil immersion by dark, shrunk
nuclei, or by nuclear segmentation (17). 200 cells were counted
per replicate. To obtain the number of apoptotic macrophages,
the percentage of apoptotic cells was applied to total nonadherent
cell numbers.
 
Production of TNF-
 
 
 
.
 
The content of TNF-
 
 
 
 in BAL fluid
was measured by a sandwich ELISA technique according to a
protocol provided by the manufacturer, using two cytokine-spe-
cific mAbs, one of which was biotinylated (BD PharMingen).
The reaction was revealed with alkaline phosphatase–conjugated
streptavidin (BD PharMingen) using paranitrophenol phosphate
(Sigma-Aldrich) as substrate. Recombinant murine TNF-
 
 
 
 (BD
PharMingen) was used as positive control.
 
Administration of Anti-FasL In Vivo.
 
Affinity purified anti–
mouse FasL mAb MFL4 (18), or normal hamster IgG were in-
jected intraperitoneally into BALB.wt mice (0.5 mg/mouse/day)
on days 0, 3, 6, 9, and 12 after silica instillation. At day 15, animals
were killed and analysed for silicosis induction by lung MPO ac-
tivity, TNF-
 
 
 
 content in BAL fluid, and lung histopathology.
 
Results
FasL-deficient gld Mice Do Not Develop Silicosis. Mutant
gld mice express a loss-of-function mutation in FasL, lead-
ing to lack of Fas-mediated apoptosis, autoimmunity, and
lymphoproliferative disorder (19). To investigate the re-
quirement of FasL on silica-induced pulmonary inflamma-
tion, BALB.wt and FasL-deficient BALB.gld mice were in-
stilled with silica intratracheally. This model of silica
exposure leads to acute pulmonary inflammation after 2
wk, followed by a chronic inflammatory response by 12 wk
(20). Silica instillation in BALB.wt mice results in large
granulomatous nodules, with increased collagen and elastic
fiber content in the pulmonary parenchyma after 15 d (21).
We studied the mice 15 d after silica instillation throughout
the experiments. Silica-treated BALB.wt mice showed se-
vere wasting, with loss of 43% of their body weight, com-
pared with saline-instilled controls (Fig. 1 A). Silica-treated
BALB.gld mice appeared healthy, without any weight loss
(Fig. 1 A). A 3.3-fold increase in levels of TNF-  was de-
tected in BAL fluid of silica-treated BALB.wt mice (Fig. 1
B). Treatment of BALB.gld mice with silica did not in-
crease basal levels of TNF- , which were elevated com-
pared with wt mice (Fig. 1 B). Induction of acute silicosis
was evaluated by respiratory mechanics (Fig. 1 C) and
histopathology (Fig. 1, D–F). Lungs from silica-treated
BALB.wt mice showed increased elastance (not shown),
and resistive ( P1) and viscoelastic/inhomogeneous ( P2)
pressures, compared with saline-instilled controls (Fig. 1
C). Silica-treated BALB.gld mice showed no change in res-
piratory mechanics (Fig. 1 C). Histological evaluation of
silica-treated BALB.wt mice demonstrated interstitial and
alveolar edema, granulomatous nodules with large accumu-
lations of inflammatory cells, mainly neutrophils and mac-
Figure 1. FasL-deficient mice do
not develop silicosis. (A) Weight loss.
Mice were instilled with saline
(white bars) or silica (black bars) in-
tratracheally. BALB.wt, but not
FasL-deficient BALB.gld mice lost
weight (P   0.05, n   6; NS, n   6,
respectively). (B) TNF-  produc-
tion. BALB.wt, but not BALB.gld
mice increased BAL levels of TNF- 
after silica instillation (P   0.05, n  
4; NS, n   4, respectively). (C) Res-
piratory mechanics. BALB.wt, but
not BALB.gld mice increased lung
total ( Ptot), resistive ( P1), and vis-
coelastic/inhomogeneous ( P2) pres-
sures after silica instillation (P   
0.01,  n     6; NS, n     6, respec-
tively). SIL, silica. (D–F) Histopa-
thology of lung sections from wt and
gld mice. Top and bottom fields
highlight areas of lung parenchyma
and bronchial cross-sections, respec-
tively. (D) Normal aspect of lung tis-
sue from BALB.wt mice after saline
instillation. (E) Intense alveolitis and
heavy nodular infiltration of neutro-
phils and macrophages in lung from
BALB.wt mice after silica instillation.
(F) Normal aspect of lung tissue from
BALB.gld mice after silica instillation.
Hematoxylin and eosin staining.
Original magnification:  200.158 FasL Triggers Silicosis
rophages, as well as alveolar collapse and intrabronchial
cellular infiltration obstructing the lumen (Fig. 1 E). Im-
munohistochemistry also revealed the presence of T cells
in inflammatory infiltrates (not shown). No inflammatory
change in pulmonary tissue was observed in silica-treated
BALB.gld mice (Fig. 1 F, compared with Fig. 1 D). Exami-
nation of lungs after 30 d of silica instillation similarly failed
to reveal any changes in gld mice (not shown). The cellular
composition of BAL fluid was examined. BAL from con-
trol mice instilled with saline typically contained  95%
macrophages (see Fig. 2 C). The differential count of BAL
cells from control mice (n   3, mean   SE) was: 96.7  
0.3% macrophages, 1.5   0.4% neutrophils, and 2.4  
0.3% lymphocytes. Silica-treated BALB.wt mice showed a
large influx of macrophages (12-fold increase in number)
and neutrophils (11,600-fold increase) into BAL fluid (Fig.
2, A and C). There was also an influx of lymphocytes (84-
fold increase), resulting in a differential cell count (n   3,
mean   SE) of: 13.2   1.6% macrophages, 84.3   1.5%
neutrophils, and 2.2   0.4% lymphocytes. BAL fluid from
control BALB.gld mice contained 86.0   1.2% macro-
phages, 1.6   0.3% neutrophils, and 14.0   1.0% lympho-
cytes. In spite of the absence of silicosis, BAL fluid from sil-
ica-treated BALB.gld  mice contained a large number of
inflammatory cells, most of which were macrophages (25-
fold increase in number), as shown in Fig. 2, A and C.
Strikingly, the number of neutrophils in BAL from silica-
treated  gld mice (506-fold increase) was reduced 6-fold,
compared with wt mice (Fig. 2, A and C). There was also
an influx of lymphocytes (13-fold increase), resulting in a
differential cell count of: 68.3   2.2% macrophages,
28.3   1.5% neutrophils, and 5.5   1.6% lymphocytes.
These results demonstrate that gld mice have both an abso-
lute and relative deficiency in neutrophil extravasation in
response to silica. Deficient neutrophil extravasation was
also evident in assays of neutrophil MPO enzymic activity
of gld BAL cells (Fig. 2 B, left). Different from wt mice,
MPO activity failed to reveal any neutrophil accumulation
in lung parenchyma from gld mice after BAL removal (Fig.
2 B, right). These results indicate that the reaction of gld
mice to silica was not pathogenic. The results also indicate
that functional FasL expression is required for massive neu-
trophil extravasation into the lungs, and for development of
interstitial lung inflammation.
Pulmonary Macrophages Expressing FasL Trigger Silicosis.
The cell type initiating silicosis could be either of bone
marrow origin, or derived from lung parenchyma. To in-
vestigate this issue, we made bone marrow radiation chi-
meras. 1 mo after reconstitution, chimeras were instilled
with silica. As shown in Fig. 3 A, silicosis developed in
wt→gld chimeras expressing nonfunctional tissue FasL, but
failed to develop in gld→wt chimeras expressing nonfunc-
tional FasL on bone marrow cells. The results with intersti-
tial MPO activity were confirmed by histological analysis
(not shown). These data indicate that cells of bone marrow
origin expressing FasL, most likely pulmonary macro-
phages, initiate silicosis. To confirm the role of macrophages,
intratracheal adoptive transfer of wt alveolar macrophages
into gld recipients was performed 5 d before silica instilla-
tion (Fig. 3 B). Transfer of 106 BAL macrophages from
Figure 2. Deficient neutrophil extravasation in FasL-
deficient mice. (A) Macrophage and neutrophil numbers
in BAL fluid from mice instilled with PBS or silica intratra-
cheally. Silica exposed BALB.gld mice (black bars) showed
a 5.8-fold reduction in neutrophil number (P   0.01, n  
4), and a 4.0-fold increase in macrophage number (P  
0.01, n   4), compared with BALB.wt mice (white bars).
SIL, silica. (B) MPO activity. Mean MPO activity of both
BAL cells and lung parenchyma of wt and gld mice instilled
with PBS alone (n = 4 pools of 3 mice each) was taken as
100% of control value. Left: MPO activity of BAL cells
from mice instilled with silica. Cells from BALB.gld ( )
mice had much less MPO activity than cells from
BALB.wt ( ) mice (P   0.05). Right: after BAL removal,
lung parenchyma from BALB.wt ( ), but not from
BALB.gld ( ) mice, had significant MPO activity, com-
pared with PBS-instilled controls (P   0.01, and NS, re-
spectively). (C) Cytospin aspect of BAL cells. BAL cells
were cytocentrifuged and stained with May-Grunwald.
Top: BAL cells from BALB.wt mice after saline instillation
were unstimulated alveolar macrophages. Middle: BAL
cells from BALB.wt mice after silica instillation were
mainly neutrophils, a minority were large macrophages.
Bottom: BAL cells from BALB.gld mice after silica instilla-
tion were mainly large macrophages, a minority were neu-
trophils. Original magnification:  630.159 Borges et al.
normal BALB.wt donors, but not from normal BALB.gld
donors, allowed silicosis to develop in gld recipients (Fig. 3
B). FasL and Fas expression were immunolocalized in tissue
sections from silica-exposed lungs (Fig. 4), and compared
with sections stained with control hamster IgG (Fig. 4 A).
Both FasL (Fig. 4 B) and, to a lesser extent, Fas (Fig. 4 C)
staining were concentrated in granulomatous nodules con-
taining macrophages that had ingested silica particles.
Moreover, FasL expression was nearly absent in control sa-
line-exposed lungs (Fig. 4 D), but was markedly upregu-
lated in silica-exposed lungs (Fig. 4 E). Fas expression was
detected in control lungs, but was also upregulated in silica-
exposed lungs (Fig.4, F and G). We investigated FasL ex-
pression in macrophages by double staining immunofluo-
rescence (Fig. 5 A). In control lung sections, F4/80 
macrophages did not express FasL (Fig. 5 A, left), while in
silica-exposed lungs, F4/80  macrophages were positive
for FasL (Fig. 5 A, right). In silica-exposed sections, a small
percentage (near 5%) of FasL  cells were negative for F4/
80 staining, and morphologically resembled activated lym-
phocytes. In addition, silica-exposed macrophages were
also positive for Fas staining. As a control, after treatment
with Fc block, macrophages from saline- and silica-exposed
lung sections did not stain for labeled control hamster IgG
(data not shown). FasL staining was absent in parenchymal
cells and in infiltrating neutrophils from silica-exposed
lungs (not shown). We also investigated induction of FasL
expression in lung macrophages in vitro. Exposure to silica
particles induced FasL expression in lung macrophages
from control wt mice (Fig. 5 B). FasL expression could be
blocked by simultaneous addition of deferoxamine, an in-
hibitor of iron-dependent free radical reactions (22; Fig. 5
B). Exposure to silica in vitro induced apoptosis in lung
macrophages from wt, but not from gld donors (Fig. 5 C).
Blockade of FasL with neutralizing anti-FasL mAb pre-
Figure 3. FasL-expressing macrophages initiate silicosis. (A) The cell
type initiating silicosis is of bone marrow origin. MPO activity in the
lungs of BALB.wt, BALB.gld mice, and the indicated chimeras, instilled
with either saline ( , ) or silica ( , ). Only mice with functional (wt)
FasL on bone marrow cells accumulated neutrophils in the lung (P  
0.01). (B) FasL-expressing lung macrophages initiate silicosis. Left: MPO
activity of BALB.wt mice treated with saline ( ) or silica ( ) were taken
as controls. Right: MPO activity in the lung parenchyma of wt ( ) or
FasL deficient gld mice ( , ), adoptively transferred intratracheally with
wt ( , ) or gld ( ) lung macrophages before silica instillation. Local
transfer of wt (P   0.01), but not of gld macrophages (NS), restored the
ability of gld mice to develop silicosis.
Figure 4. FasL and Fas expression in vivo. (A–C) Immunohistochemistry of lung tissue from BALB.wt mice instilled with silica. Lung sections were
stained with control hamster IgG (A), anti-FasL (B), or anti-Fas (C) mAbs, and revealed by immunoperoxidase. Silica deposition induces FasL (B) and in-
creases Fas (C) expression, compared with control hamster IgG (A). FasL staining is restricted to granulomatous nodules containing silica; both unaltered
areas of parenchyma and epithelia were negative. Original magnification:  200. (D–G) Higher magnification aspects of FasL (D and E) and Fas (F and G)
expression in lung tissue from BALB.wt mice instilled with either saline (D and F) or silica (E and G). FasL expression is absent, and Fas expression is low
in saline-instilled lung sections. Original magnification:  630.160 FasL Triggers Silicosis
vented macrophage apoptosis almost completely (Fig. 5 C).
Taken together, the results indicate that interaction with
silica particles induces FasL expression and FasL-mediated
apoptosis of pulmonary macrophages.
Administration of Anti-FasL mAb In Vivo Blocks Develop-
ment of Silicosis. We sought evidence that in vivo block-
ade of FasL would prevent silicosis (Fig. 6). BALB.wt mice
were instilled with silica and treated with 2.5 mg of neutral-
izing anti-FasL mAb MFL4 (18) divided into five intraperi-
toneal injections at 3 d intervals. Control BALB.wt mice
were treated with a similar protocol using normal hamster
IgG. Treatment with anti-FasL Ab prevented almost com-
pletely neutrophil accumulation into lung parenchyma,
compared with control mice, as measured by MPO activity
(Fig. 6 A). Furthermore, the increase in TNF-  levels was
completely prevented by in vivo treatment with anti-FasL
Ab (Fig. 6 B). These results were confirmed by histopatho-
logical analysis. Except for a discrete macrophage infiltrate,
mice treated with anti-FasL had lungs with morphology
comparable to negative controls (Fig. 6, C and E), and dif-
ferent from the heavily inflamed lungs of mice treated with
control IgG (Fig. 6 D). Taken together, these results dem-
onstrate a pivotal role of FasL in induction of silicosis in
vivo, and suggest that apoptotic cell death is required for
neutrophil extravasation and pulmonary inflammation.
Discussion
Our data with pulmonary silicosis provide the first evi-
dence of a FasL-mediated inflammatory disease mounted
by the innate immune response. Previous studies have
demonstrated that T lymphocytes modulate, but are not
absolutely required in murine silicosis (23). We have used a
model of silica instillation (20, 21), where the dosage of sil-
ica can be controlled. The role of FasL should also be con-
firmed using silica inhalation (24), which more closely re-
sembles occupational silica exposure. Silica instillation into
mice leads to acute and chronic pulmonary inflammation
with some characteristics resembling human silicosis, in-
cluding acute neutrophilic extravasation and increased pro-
tein and phospholipid content of BAL fluid (23), as well as
progressive fibrosis (20, 21, 23). In this study, we investi-
gated the role of FasL in lung inflammation after 15 and 30
d of silica exposure. The role of FasL in chronic silicosis re-
mains to be investigated. However, it should be noted that
long term (1 yr) alterations in lung have been described
even after a single administration of silica (25).
TNF-  plays a central role in pulmonary inflammation
(3) and fibrosis (4) induced by silica deposition. Here we
demonstrate a pivotal role for FasL in a mouse model of
pulmonary silicosis, and locate its action upstream of TNF- .
FasL is also proinflammatory in other conditions. Forced
expression of FasL in tumors and grafts induces a host neu-
trophilic infiltration that accelerates rejection (9, 10, 26).
Moreover, FasL is chemotactic for neutrophils in vitro (27)
and in vivo (28, 29), and transduces neutrophil p38 mito-
gen-activated protein kinase (MAPK) activation (11). Lack
of silicosis in gld mice indicates that functional FasL triggers
the molecular and cellular pathways of pulmonary inflam-
mation. Further support for this concept is that in vivo ad-
ministration of a neutralizing anti-FasL mAb prevents de-
velopment of silicosis.
FasL expression can be induced in nonlymphoid tissue
(30). However, the cell type initiating murine silicosis is of
bone marrow origin. These results exclude a major role for
epithelial cell damage or other contribution from lung pa-
renchyma in early steps of silicosis. Adoptive transfer of sil-
icosis to gld mice by wt alveolar macrophages confirmed
their essential role, and implied that activated macrophages
must express FasL. We showed that silica exposure induces
FasL expression in lung macrophages in vivo and in vitro.
It is known that reactive oxygen intermediates induce FasL
expression (31), and that treatment with a free radical scav-
enger compound alleviates silicosis (32). Deferoxamine, an
inhibitor of reactive oxygen intermediate production (22),
prevented FasL expression induced by silica. In agreement
with previous studies (17), silica induced macrophage apop-
tosis in vitro. We showed that macrophage apoptosis is
mediated by FasL. First, gld macrophages did not apoptose
in response to silica. Second, wt macrophage apoptosis
could be blocked with anti-FasL mAb. These results indi-
cate that FasL expression is induced after oxidant injury
provoked by silica, and that FasL expression results in mac-
rophage apoptosis. Exposure of macrophages to other par-
ticulate stimuli also upregulates Fas and FasL expression,
Figure 5. Silica induces FasL expression in macrophages. (A) Macro-
phages express FasL in vivo. Double staining immunofluorescence of lung
macrophages from wt mice instilled with saline (left) or silica (right). Top:
differential image contrast (DIC) microscopy of selected fields. Middle:
staining of FITC-labeled F4/80  macrophages in the same fields. Bot-
tom: simultaneous staining of PE-labeled FasL  macrophages in the same
fields. Only silica-exposed F4/80  macrophages stained for FasL expres-
sion. After Fc block, normal and silica-exposed macrophages did not stain
for PE-labeled control hamster IgG (not shown). Original magnification:
 630. (B) Macrophages express FasL in vitro. FasL expression in normal
wt BAL macrophages cultured with medium or silica in the absence
(white bars) or in the presence (black bars) of deferoxamine (DFO). FasL
expression was measured by cell ELISA. Silica induced FasL expression
(P   0.05), which was prevented by DFO (P   0.05). (C) Silica induces
FasL-dependent macrophage apoptosis. Apoptosis in BAL macrophages
from normal gld and wt mice treated with silica in the presence of control
hamster IgG or anti-FasL. Silica induced apoptosis in wt (P   0.01), but
not in gld (NS) macrophages; apoptosis was prevented by anti-FasL (P  
0.01). SIL, silica.161 Borges et al.
and triggers release of soluble FasL, which affects the viabil-
ity of macrophages and bystander neutrophils (33, 34). Re-
cently, alveolar and inflammatory cell apoptosis mediated
by FasL were described in acute lung injury induced in
mice by bacterial LPS (35). A pathogenic role for FasL was
suggested, as administration of anti-Fas antibody reduced
albumin leakage into BAL fluid (35).
The gld mice had markedly impaired neutrophil extrava-
sation, and lacked pulmonary inflammation. These data
support a major chemotactic role for FasL (9, 10, 26, 29),
and indicate that neutrophils are the effector cells of lung
injury. However, FasL does not account for all cellular
changes in lungs exposed to silica. Macrophage recruitment
into BAL fluid is increased in gld mice, suggesting that it is
FasL independent. As the pulmonary parenchyma of gld
mice was normal, these results indicate that in the absence
of a FasL signaling cascade, leukocytes migrating from the
blood locate in the alveolar space and are eliminated.
The factors that drive the FasL reaction to either silent
apoptosis or acute neutrophilic infiltration are unclear. Lo-
cal levels of either TGF-  (11) or soluble FasL (29) could
suppress the neutrophilic response, and lead to immune
privilege. On the other hand, Fas signaling is proinflamma-
tory, as it results in activation of caspase-1 (36). Caspase-1
cleaves and activates the proinflammatory cytokines IL-1 
and IL-18 (36). In fact, apoptosis mediated by FasL releases
IL-1  from dying cells (28). Furthermore, FasL induces IL-
18 secretion from macrophages, leading to acute liver in-
jury (37). In the absence of immune privilege inducing fac-
tors, IL-1, and possibly other cytokines and chemokines
released by apoptosis, could be responsible for neutrophil
extravasation (29). Thus, one interpretation for our results
is that continual interaction with silica particles induces
FasL-mediated macrophage apoptosis, releasing chemotac-
tic factors for neutrophils. Neutrophils in turn, would
phagocytose dying cells and damage the lung parenchyma
by releasing toxic oxygen metabolites, hydrolytic enzymes,
and TNF- . In support of this model, we found apoptotic
cells in silica induced inflammatory infiltrates, and in vivo
administration of caspase inhibitors alleviated neutrophil
infiltration (data not shown). There was a small percentage
of FasL  cells resembling lymphocytes in silica-induced in-
flammatory nodules. However, the critical role of lung
macrophages is supported by the adoptive transfer of silico-
sis they mediate, and by previous studies showing that in-
duction of experimental silicosis does not require T cells
(23).
Our data, and previous studies (9, 10, 26, 28, 29), dem-
onstrate a proinflammatory role for apoptosis. In contrast,
there is evidence that phagocytosis of apoptotic cells plays
an antiinflammatory role (38, 39), and downregulates nitric
oxide production by macrophages (39). The reason for
these differences is not clear. However, lung macrophages
are deficient in the phagocytosis of apoptotic cells (40),
suggesting that further changes in apoptotic cell membrane
and release of intracellular mediators are allowed.
An important issue is whether the role of FasL can be
extended to human silicosis. Increased levels of soluble
FasL were reported in patients with silicosis (41). As locally
produced soluble FasL can induce bystander neutrophil
Figure 6. FasL blockade prevents sil-
ica-induced inflammation. (A) MPO ac-
tivity in mice instilled with silica. Treat-
ment with anti-FasL mAb MFL4 (NS
compared with saline; n     4), but not
with control IgG (P   0.01, n   4), pre-
vented increased MPO activity induced
by silica in lung parenchyma. SIL, silica.
(B) TNF-  production. Treatment with
anti-FasL (NS compared with saline, n  
4), but not with control IgG (P   0.01,
n   4), prevented increased TNF-  pro-
duction in BAL fluid from silica exposed
mice. (C–E) Histopathology of lung sec-
tions. (C) Normal aspect of lung tissue af-
ter saline instillation. (D) Intense pulmo-
nary inflammation in mice instilled with
silica and treated with control hamster
IgG. (E) Lung tissue from mice instilled
with silica and treated with anti-FasL
mAb. Morphology comparable to C, ex-
cept for a discrete macrophage infiltrate.
Hematoxylin and eosin staining. Original
magnification:  200.162 FasL Triggers Silicosis
apoptosis (34), and blocks further neutrophil extravasation
in mice (29), soluble FasL could play a role in modulation
of silica-induced inflammation in humans. The finding of a
central role of FasL in experimental silicosis could provide
clues for the pathogenesis and treatment of this common
and life-threatening occupational disease.
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